科研之友
微信
新浪微博
Facebook
分享链接
摘要
Batches of mesoporous poly(lactide-co-glycolide) (PLGA) microspheres were fabricated via an O/W emulsion-solvent evaporation method. The obtained microspheres were detected with scanning electron microscopy (SEM, S-4800) to observe their surface morphology. On observation it was found that many macropores were distributed on the microsphere surfaces. Then, eprinomectin (EPR) was employed as a model drug and was encapsulated by these mesoporous microspheres. The distribution state of the EPR in the microspheres was investigated via X-ray diffraction and differential scanning calorimetry. The test results indicated that the EPR was distributed in the microspheres with an amorphous state. After re-dispersing the EPR-loaded microspheres in ultrapure water, an extended-release formulation of EPR was obtained. The formulation was administered to Japanese white rabbits by subcutaneous injection to monitor the blood concentration of EPR. Plasma concentration profiles showed that the C-max of EPR (38.80 +/- 9.50 ng mL(-1)) appeared on the 2nd day after subcutaneous injection. During the next 40 days, the plasma concentration of EPR maintained a value of 30.0 ng mL(-1). In addition, the biocompatibility of the EPR-loaded mesoporous microspheres (EPM) was also investigated by a biological sectioning method. Photographs of the histological sections illustrated that the EPM did not trigger a serious stimulus response at the injection site. Thus, they could be used to affirm that the mesoporous microspheres have a promising application in controlling veterinary drugs for sustained release.
- 出版日期2015
- 单位河北科技大学
